Islay Capital Management’s Boston Scientific BSX Stock Holding History

Islay Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-255	Closed	-$13.5K	–	223
2023 Q3	$13.5K	Hold	255	–	–	0.01%	172
2023 Q2	$13.8K	Hold	255	–	–	0.01%	172
2023 Q1	$12.8K	Hold	255	–	–	0.01%	174
2022 Q4	$11.8K	Hold	255	–	–	0.01%	190
2022 Q3	$10K	Hold	255	–	–	0.01%	209
2022 Q2	$10K	Sell	255 -1,400	-85%	-$57K	0.01%	233
2022 Q1	$73K	Sell	1,655 -3,400	-67%	-$147K	0.06%	179
2021 Q4	$215K	Sell	5,055 -1,097	-18%	-$46.1K	0.16%	75
2021 Q3	$267K	Hold	6,152	–	–	0.21%	67
2021 Q2	$263K	Sell	6,152 -2,500	-29%	-$105K	0.21%	67
2021 Q1	$334K	Sell	8,652 -8,509	-50%	-$322K	0.28%	60
2020 Q4	$617K	Sell	17,161 -73	-0.4%	-$2.63K	0.56%	40
2020 Q3	$659K	Sell	17,234 -1,731	-9%	-$66.7K	0.68%	34
2020 Q2	$666K	Sell	18,965 -4	-0%	-$144	0.77%	28
2020 Q1	$619K	Buy	+18,969	New	+$741K	0.81%	29

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Islay Capital Management's BSX Position: Q4 2023 in Review

Islay Capital Management sold out of Boston Scientific (BSX) in Q4 2023, closing a stake of 255 shares — an estimated $13.5K sold.

Islay Capital Management first reported a position in BSX in Q1 2020 and held it in 15 quarters. The position peaked at $666K in Q2 2020. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

Islay Capital Management reported no remaining Boston Scientific position as of Q4 2023 after selling out during the quarter.
Islay Capital Management sold 255 Boston Scientific shares in Q4 2023, an estimated $13.5K.
Islay Capital Management first reported a position in Boston Scientific in Q1 2020 and held it in 15 quarters.
Islay Capital Management's Boston Scientific position peaked at $666K in Q2 2020.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Islay Capital Management's 13F filing for Q4 2023, filed 5 Feb 2024.